Carregant...
Pharmacogenetics of Dopamine β-Hydroxylase in Cocaine Dependence Therapy with Doxazosin
BACKGROUND: The α(1) adrenergic antagonist, doxazosin, has improved cocaine use disorder (CUD) presumably by blocking norepinephrine (NE) stimulation and reward from cocaine-induced NE increases. If the NE levels for release were lower, then doxazosin might more readily block this NE stimulation and...
Guardat en:
| Publicat a: | Addict Biol |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6119656/ https://ncbi.nlm.nih.gov/pubmed/29498170 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/adb.12611 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|